Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations
US11975202B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2023 |
| Grant date | May 7, 2024 |
| Priority date | — |
| Expiry date | Jul 17, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H20/40
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Disclosed are methods to treat patients with AFib by monitoring their heart rhythm to determine the presence and/or the number of episodes of long duration AFib, and optionally the extent of AFib burden. Patients who meet threshold requirements are qualified for the treatment of AFib with a dosage of budiodarone. Patient monitoring is continued in order confirm that the patient is and remains responsive to budiodarone therapy including dose adjusting the patient to achieve such therapy. Subsequently, monitoring is continued to confirm that the patient remains responsive. These methods allow for treatment of the AFib and, correspondingly, reduce or delay the risk of stroke and/or congestive heart failure in the treated patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.